Introduction: Retrograde peri-implantitis (RPI) is defined as a clinically symptomatic periapical lesion that develops shortly after implant insertion while the coronal portion of the implant sustains a normal bone-to-implant interface. The etiology of RPI is unclear and may be attributed to several causes. Regardless of etiology, the management of RPI has been attempted by either resective or regenerative techniques.
incidence of RPI based on a handful of studies ranges from <1% 2 to 9.9%. 3, 4 Additional reports have described the presence of RPI in one or two cases. 5, 6 The etiology of RPI 6, 7 is unclear and may be attributed to several causes, including implant surface contamination, overheating during preparation or placement, residual bacteria in the implant site, presence of adjacent endodontic lesions, and drainage of inflammation from marrow spaces. Additional causes may be violation of minimal distance from adjacent teeth, residual root particles or foreign bodies, surgical drilling beyond the length of the implant, fenestration of vestibular bone, bone compression, poor bone quality, premature loading, development of osteomyelitis, technique of the implant system used, and bone loss as a result of a flap procedure. 7 A search of the literature reveals a paucity of information about the etiology of RPI. Regardless of etiology, the management of RPI has been attempted by either regenerative 1, [8] [9] [10] [11] [12] [13] or resective 10, 14, 15 techniques. Isolated reports have described the use of debridement 16 or antibiotics alone 17 for its management. Reports citing the success of both approaches are available. 1, 15 In a retrospective study by Quirynen et al., 3 10 (seven maxillary and three mandibular) of 539 implants were treated for RPI using regenerative techniques. One of the mandibular implants was lost after an 18-month follow-up. In another retrospective study, Balshi et al. 4 treated 39 of 395 implants for RPI using resective techniques and followed these cases for 4 to 15 years. Of the 39 implants, 38 were successfully treated with this technique.
In this case report, the management of RPI involving two of three implants placed in the anterior maxilla using an apical resective approach with guided bone regeneration (GBR) is described.
Clinical Presentation
A 61-year-old male was referred to the graduate periodontics clinic of the University of Detroit Mercy, School of Dentistry (UDMSOD), Detroit, Michigan, on October 23, 2009, with a chief complaint of, ''I have three implants that I am concerned about and would like an evaluation.'' The patient had been treated multiple times with antibiotics with no permanent resolution of the fistula associated with implant #8.
Evaluation at UDMSOD included a thorough periodontal (Fig. 1a) and dental exam, radiographs (Fig. 1b) , and cone-beam computed tomography (CBCT) (Figs. 1c  and 1d) . A thorough occlusal analysis was conducted, and no occlusal discrepancies were detected.
After careful discussion of all treatment options, the decision to resect the apical portion of the implants and perform regenerative therapy was made because of the extensive nature of the lesion (erosion of buccal and palatal cortical plates as detected by CBCT) and the fact that we could not access the apical and palatal areas for debridement.
Case Management
On the day of the surgery, written informed consent was obtained. A full-thickness flap was reflected from both the buccal and palatal aspects to ensure proper access to the underlying implant-associated lesions (Video 1). The The patient gave a history of multiple episodes of fistula formation, which were managed using only oral antibiotics. 1a A clinical exam revealed probing depths around all implants ranging from 2 to 4 mm with no bleeding on probing and no mobility and the presence of a fistula apical to implant #8 (black arrow). 1b A periapical radiograph revealed the presence of radiolucencies associated with the apices of implants #8 and #9 and marginal discrepancy of the implant-supported crowns. 1c The buccofacio (Fac)-palatal (Pal) extent of osseous destruction was assessed using CBCT. Implant #8 was in close proximity to the nasopalatine canal with perforation of the palatal cortical plate. The periapical lesion (green arrow) completely enveloped the apical portion of the implant and extended approximately half the length of the implant on the palatal aspect. 1d Implant #9 showed less osseous destruction in the form of a smaller palatal and apical lesion with a perforation on the labial aspect (green arrows). preexisting fenestrations were enlarged with a round carbide bur † (Fig. 2) , biopsy samples were obtained, and the affected one third of the implants were amputated with burs. ‡ Care was taken to reduce generation of heat by using copious irrigation and very light pressure. A particular concern was the proximity of implants #7 and #8, and, therefore special care was taken to avoid gouging the bony walls separating them. The residual bony cavities were treated by bathing in 300 mg/2 mL clindamycin solution x for 3 minutes, using a collagen barrier k on the palatal aspect of implant #8, demineralized bone matrix putty { (Figs. 3 and 4) , and another collagen barrier # on the facial aspect (Fig. 5) . Surgical wound closure was completed (Fig. 6) , and a postoperative radiograph was taken (Fig. 7) . The patient was prescribed postoperative medications (azithromycin,** 250 mg 2 tablets stat, 1 tablet daily until gone; chlorhexidine gluconate, † † 0.12% twice daily; lbuprofen, ‡ ‡ 600 mg, every 6 to 8 hours as needed for pain) and given postoperative instructions to refrain lifting the upper lip, brushing the surgical area, or incising food using the anterior teeth.
Clinical Outcomes
The patient was recalled for postoperative visits at 1, 2, and 4 weeks. The histopathologic analysis was consistent with the diagnosis of a periapical granuloma (Fig. 8 ).
At the 6-month postoperative visit, soft-tissue healing was unremarkable, and the periapical radiograph displayed increasing radiodensity around both implants. At 1 year, radiographs revealed both lesions around implants #8 and #9 appeared to be resolving. The lesion associated with implant #9 had a more remarkable radiographic change, because it was smaller than the lesion around implant #8. Both implants continued to function with no recurrence of fistula formation. The crestal bone level remained stable, and no changes in probing depth or mobility were noted (Fig. 9 ).
Discussion
Management of RPI has been attempted using techniques such as debridement alone 16 or in combination with osseous grafts and/or barriers. Use of antibiotics alone or with additional regenerative materials has also been documented. [8] [9] [10] 14 Reports in the literature on the management of these lesions by antibiotics alone have had poor outcomes. 9, 14 The other surgical option, which also focuses on retention of the implant, is resection. 4, 10, 14, 15 Resective techniques follow a similar protocol, with the primary difference being the resection of the infected apical portion of the implant. Balshi et al. 4 treated 39 cases with resective therapy and used bovine bone to graft the defects. A collagen membrane was placed over the larger defects. The follow-up time averaged 4.5 years, with 15 years being the longest follow-up. All but one of the 39 implants treated with this technique was successfully retained. The protocol of Dahlin et al. 15 after resection consisted of irrigation with saline and postoperative systemic antibiotics. The 3-year follow-up of the two cases, with two implants total, revealed complete bone fill into the resected area. The bone levels around the implants were stable, and the patients remained asymptomatic.
In our case report, after assimilating all diagnostic information, the following treatment options were discussed with the patient: 1) implant resection and GBR; 2) implant surface decontamination and GBR; and 3) removal of implants, GBR, and placement of new implants in 6 months. Our clinical approach was similar to the above reports. 4, 15 A full-thickness buccal and palatal flap was elevated because of the extensive nature of the lesion. Similar to the protocol of Balshi et al., 4 the size of the buccal fenestration had to be increased to provide access to the apical lesion. Although only two thirds of the implants threads were covered with bone, both implants were immobile. The decision to surgically access the implant apices and use resective techniques was based primarily on the fact that complete debridement of the infected implant portions would be impossible given the extent of the lesions. A combination of resective treatment, antibiotic decontamination of the surgical sites, and regenerative therapy is a viable treatment modality for the management of RPI. This case was followed for 1 year, and both lesions in the areas of implants #8 and #9 appeared to be resolving with no clinical symptoms. The lesion of implant #9 had a more remarkable radiographic change compared to the size and extent of the lesion on implant #8. An additional regenerative procedure may be indicated at this site in the future. Both implants continued to function with no recurrence of fistula formation. n Summary Why is this case new information?
j We highlight the fact that a combination of resective and regenerative therapy is a viable treatment modality for RPI cases that range in small to large areas of bone destruction. This combination of treatment can help salvage implants afflicted with RPI in the anterior areas of the mouth without compromising the coronal peri-implant esthetics.
What are the keys to successful management of this case?
j We achieved a favorable outcome in this case report because we were able to remove the affected apical portion of the implant and access and remove the surrounding pathology. The residual defects in bone were augmented with a bone graft.
What are the primary limitations to success in this case?
j For implant #8, the bucco-palatal extent of osseous destruction was significant, with perforation of the palatal cortical plate. The lesion completely enveloped the apical portion of the implant and extended approximately half the length of the implant on the palatal aspect. Implant #9 showed less osseous destruction in the form of a smaller palatal and apical lesion. j At the 12-month postoperative visit, radiographically, the apex of implant #8 appeared less radiodense compared to implant #9. This was attributed to the size and extent of the lesion around implant #8 along with the bicortical perforation.
